Engineering multifunctional nanoparticles: all-in-one versus one-for-all

被引:80
作者
Huynh, Elizabeth [1 ,2 ]
Zheng, Gang [1 ,2 ]
机构
[1] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[2] Univ Hlth Network, Ontario Canc Inst, Techna Inst, Toronto, ON, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
IRON-OXIDE NANOPARTICLES; PEGYLATED LIPOSOMAL DOXORUBICIN; LONG-CIRCULATING NANOPARTICLES; GOLD NANOPARTICLES; CANCER-THERAPY; SOLID TUMORS; MAGNETIC NANOPARTICLES; BIOMEDICAL APPLICATIONS; CONTRAST AGENT; QUANTUM DOTS;
D O I
10.1002/wnan.1217
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Multifunctional nanoparticles have been developed to overcome the conventional hurdles associated with the diagnosis and treatment of disease. However, there are often caveats involved with the development and clinical translation of multifunctional nanoparticles largely regarding the notion that additional functionality increases nanoparticle complexity. Here, we discuss two design concepts, a conventional approach, all-in-one', and introduce the concept of one-for-all' to suggest that multifunctionality does not necessarily result in multicomponent complex nanoparticles. This review focuses on the design concepts of all-in-one and one-for-all with examples of each approach and a discussion on the implications for clinical translation. WIREs Nanomed Nanobiotechnol 2013, 5:250265. doi: 10.1002/wnan.1217 For further resources related to this article, please visit the WIREs website.
引用
收藏
页码:250 / 265
页数:16
相关论文
共 99 条
  • [1] Alexiou C, 2000, CANCER RES, V60, P6641
  • [2] Targeting cancer cells: magnetic nanoparticles as drug carriers
    Alexiou, Christoph
    Schmid, Roswitha J.
    Jurgons, Roland
    Kremer, Marcus
    Wanner, Gerhard
    Bergemann, Christian
    Huenges, Ernst
    Nawroth, Thomas
    Arnold, Wolfgang
    Parak, Fritz G.
    [J]. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2006, 35 (05): : 446 - 450
  • [3] Factors affecting the clearance and biodistribution of polymeric nanoparticles
    Alexis, Frank
    Pridgen, Eric
    Molnar, Linda K.
    Farokhzad, Omid C.
    [J]. MOLECULAR PHARMACEUTICS, 2008, 5 (04) : 505 - 515
  • [4] Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]
  • [5] Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging
    Bartlett, Derek W.
    Su, Helen
    Hildebrandt, Isabel J.
    Weber, Wolfgang A.
    Davis, Mark E.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (39) : 15549 - 15554
  • [6] Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]
  • [7] Nanoparticles in photodynamic therapy: An emerging paradigm
    Chatterjee, Dev Kumar
    Fong, Li Shan
    Zhang, Yong
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (15) : 1627 - 1637
  • [8] Gold Nanocages as Photothermal Transducers for Cancer Treatment
    Chen, Jingyi
    Glaus, Charles
    Laforest, Richard
    Zhang, Qiang
    Yang, Miaoxian
    Gidding, Michael
    Welch, Michael J.
    Xia, Younan
    [J]. SMALL, 2010, 6 (07) : 811 - 817
  • [9] Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
    Cheng, Zhiliang
    Al Zaki, Ajlan
    Hui, James Z.
    Muzykantov, Vladimir R.
    Tsourkas, Andrew
    [J]. SCIENCE, 2012, 338 (6109) : 903 - 910
  • [10] Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy
    Chithrani, Devika B.
    Jelveh, Salomeh
    Jalali, Farid
    van Prooijen, Monique
    Allen, Christine
    Bristow, Robert G.
    Hill, Richard P.
    Jaffray, David A.
    [J]. RADIATION RESEARCH, 2010, 173 (06) : 719 - 728